Sign up to save your podcasts
Or
Share To boost or not to boost – Part 2
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
To boost or not to boost – Part 2
This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5.
Guest speaker:
Azra Behlim, PharmD, MBA
Associate Vice President, Pharmacy Sourcing and Program Services
Vizient
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality
Vizient
Show Notes:
[00:30] Is the booster safe?
[00:48] Efficacy
[01:32] How long to wait after previous vaccine
[02:47] Whether or not to get flu vaccines
[05:58] Feasibility of using the booster as an initial vaccine in a series
[07:52] Novavax
[09:05] Nasal vaccines and mucosal immunity
Links | Resources:
To contact Modern Practice: [email protected]
FDA announcement on new vaccine boosters (8-31-22): Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Android
Google Podcasts
Spotify
Stitcher
RSS Feed
View all episodes
By Dr. Tom Villanueva and Vizient Medical Leadership Team
4.8
2020 ratings
This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5.
Guest speaker:
Azra Behlim, PharmD, MBA
Associate Vice President, Pharmacy Sourcing and Program Services
Vizient
Moderator:
Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality
Vizient
Show Notes:
[00:30] Is the booster safe?
[00:48] Efficacy
[01:32] How long to wait after previous vaccine
[02:47] Whether or not to get flu vaccines
[05:58] Feasibility of using the booster as an initial vaccine in a series
[07:52] Novavax
[09:05] Nasal vaccines and mucosal immunity
Links | Resources:
To contact Modern Practice: [email protected]
FDA announcement on new vaccine boosters (8-31-22): Click here
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Android
Google Podcasts
Spotify
Stitcher
RSS Feed